Stock comparison
STERIS
United Therapeutics
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
STE
STERIS
Market cap
$21.26B
Sector
Healthcare
UTHR
United Therapeutics
Market cap
$24.13B
Sector
Healthcare
Overall winner
United Therapeutics UTHR
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | STE | UTHR | Winner |
|---|---|---|---|
| Warren Buffett | 53C | 71B | UTHR |
| Benjamin Graham | 68B | 76B | UTHR |
| Philip Fisher | 58C | 76B | UTHR |
| Peter Lynch | 52C | 62C | UTHR |
| Joel Greenblatt | 35D | 46D | UTHR |
| Charlie Munger | 42D | 64C | UTHR |
| Terry Smith | 48D | 64C | UTHR |
Side-by-side metrics
| Metric | STE | UTHR |
|---|---|---|
| Market cap | $21.26B | $24.13B |
| P/E (TTM) | 25.3x | 19.2x |
| EV/EBIT | 17.7x | 15.2x |
| ROIC (TTM) | 8.51% | 18.81% |
| Gross margin | 44.25% | 86.58% |
| Net margin | 13.18% | 40.61% |
| Revenue CAGR 5y | 8.88% | 17.22% |
| EPS CAGR 5y | 33.45% | 29.84% |
| Debt / Equity | 0.0x | - |
| Dividend yield | 1.22% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
STE leads on
- Dividend yield1.22%vs 0.0%+100%
- EPS CAGR 5y33.45%vs 29.84%+11%
UTHR leads on
- Debt / Equity-vs 0.0x+100%
- Net margin40.61%vs 13.18%+68%
- ROIC (TTM)18.81%vs 8.51%+55%
- Gross margin86.58%vs 44.25%+49%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.